Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Compliance With Treatment by Elvitegravir/Cobicistat/FTC/Tenofovir Alafenamide (E/C/F/TAF) in HIV Post-exposure Prophylaxis (to Infected Blood or Sexual Contact)

NCT02998320 is registered in ClinicalTrials.gov with Groupe d'Etude sur le Risque d'Exposition des Soignants aux Agents Infectieux as lead sponsor.

NCT NCT02998320
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02998320 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Compliance With Treatment by Elvitegravir/Cobicistat/FTC/Tenofovir Alafenamide (E/C/F/TAF) in HIV Post-exposure Prophylaxis (to Infected Blood or Sexual Contact)
Lead sponsor
Groupe d'Etude sur le Risque d'Exposition des Soignants aux Agents Infectieux
Phase
Phase 3
Overall status
Completed
Start date
March 10, 2017
Completion date
September 30, 2018
Enrollment
101 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

hiv risk